The program replaces AAFCO’s now-defunct Ingredient Definition Request process, which ended following the expiration of its Memorandum of Understanding with the FDA in 2024.
Pigs have already been vaccinated and will be challenged with a virulent strain of the ASF virus to assess the vaccine’s efficacy.
The approval allows Genus to commercialise its PRRS-resistant pigs, dubbed PRP, for the U.S. market, though sales are not expected until 2026 at the earliest.
Although H5N1 remains rare in humans, its detection in cattle has raised alarm among public health experts, prompting calls for closer monitoring of those in direct contact with livestock.
Meanwhile, Nestlé’s Purina is showcasing its enhanced exhibition space at Zoomark 2025, with a special focus on its high-performance pet nutrition brand, Purina Pro Plan.
Visitors include independent pet retailers, groomers, breeders, wholesalers, e-commerce buyers, and consultants, offering unmatched networking potential for every stakeholder.
Now available across the U.S., IFF’s advanced pet care solutions aim to help manufacturers meet consumer expectations with cleaner labels, enhanced efficacy, and sustainable production methods.
A major highlight was the centralized release of 19 new technologies and products selected by the China Feed Industry Association.
Its mission is to accelerate vaccine innovation for diseases often overlooked by mainstream pharmaceutical companies.
This designation reaffirms WBVR’s critical role in international efforts to improve diagnostic tests, strengthen veterinary services, and develop science-based disease control strategies.